Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Menopause. 2012 Jun;19(6):658–663. doi: 10.1097/gme.0b013e31823fe274

Table 2.

Hormonal characteristics of the women exhibiting the four profiles determined by baseline DHEAS values and changes in subsequent annual DHEAS values (N=30)a.

Characteristic Baseline DHEAS Reference Profile 1 (N=30) Baseline DHEAS < 1 SD of Mean Profile 2 (N=30) Baseline DHEAS at Mean Profile 3 (N=30) Baseline DHEAS > 1 SD of Mean Profile 4 (N=30) p-value for overall subgroup difference
Mean (SD) Mean (SD, p profile 2 and 3) Mean (SD) Mean (SD, p profile 3 and 4)
Androstenedione (pg/mL) 1515.1 (1174.0) 973.2 (446.2, p=0.169) 927.6 (350.6) 1188.7 (344.7, p=0.210) 0.19
Androstenediol (pg/mL) 865.4 (205.3) 287.7 (139.1, p=0.117) 703.6 (327.0) 1023.8 (266.5, p=0.056) < 0.0001
DHEAS (ug/dL) 144.6 (49.5) 41.6 (14.1, p=0.004) 112.2 (39.2) 265.1 (44.3, p=0.001) < 0.0001
SHBG (nM) 46.9 (17.6) 48.7 (28.1, p=0.560) 42.3 (22.8) 32.2 (11.4, p=0.386) 0.36
Testosterone (ng/dL) 61.7 (22.9) 34.6 (23.9, p=0.553) 51.0 (32.4) 63.0 (24.1, p=8.828) 0.008
Estradiol (pg/mL) 81.2 (36.3) 79.9 (72.3, p=0.675) 59.3 (49.4) 66.4 (86.9, p=0.383) 0.26
a

The Reference Profile shows a DHEAS fall in subsequent years, while Profiles 2–4 show a fall in the subsequent year and then rise. P values are provided to illustrate the significance between the mean (Profile 3) and < 1SD below the mean (Profile 2) and between the mean (Profile 3) and > 1SD above the mean (Profile 4).